HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical…
Calgary, Alberta--(Newsfile Corp. - September 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's…
Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation FDA…
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- 'A Moment of Xen', the acclaimed Tri-State talk show hosted by celebrated media…
Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related dataEnhancing dementia research by integrating…
Zug, Switzerland--(Newsfile Corp. - September 2, 2025) - Longevity Investors, launched back in 2020 as the first industry event series…
Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European…
Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European…
Adoption of Illumina's MiSeq i100 Plus accelerates results delivery to next-day from sample receipt, speeding up patient care when time…
NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL…